Olema Pharmaceuticals
OLMA
Insider trades and stock quote 2024-2026
All insider trades at Olema Pharmaceuticals
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/24/2026
|
Sell |
Harmon, Cyrus |
Director |
$11.7 |
$146,425 |
|
7/23/2026
|
Sell |
Harmon, Cyrus |
Director |
$11.6 |
$144,738 |
|
3/4/2026
|
Sell |
Mitchell, Shawnte |
CHIEF LEGAL OFFICER |
$24.5 |
$606,353 |
|
3/3/2026
|
Sell |
Mitchell, Shawnte |
CHIEF LEGAL OFFICER |
$23.0 |
$345,150 |
|
1/20/2026
|
Sell |
Harmon, Cyrus |
Director |
$26.9 |
$268,800 |
|
1/15/2026
|
Sell |
Kovacs, Shane William Charles |
CH. OPERATING & FINANCIAL OFF. |
$28.7 |
$2,873,000 |
|
1/14/2026
|
Sell |
Myles, David C. |
CH. DISCOV. & NON-CLIN DEV OFF |
$28.8 |
$1,443,651 |
|
1/14/2026
|
Sell |
Harmon, Cyrus |
Director |
$29.1 |
$101,600 |
|
1/13/2026
|
Sell |
Kovacs, Shane William Charles |
CH. OPERATING & FINANCIAL OFF. |
$28.0 |
$107,054 |
|
1/13/2026
|
Sell |
Myles, David C. |
CH. DISCOV. & NON-CLIN DEV OFF |
$28.0 |
$1,380,178 |
|
1/12/2026
|
Sell |
Myles, David C. |
CH. DISCOV. & NON-CLIN DEV OFF |
$28.3 |
$283,400 |
|
12/23/2025
|
Sell |
Zojwalla, Naseem |
Chief Medical Officer |
$27.7 |
$2,752,419 |
|
12/22/2025
|
Sell |
Harmon, Cyrus |
Director |
$28.5 |
$82,195 |
|
12/22/2025
|
Sell |
Zojwalla, Naseem |
Chief Medical Officer |
$28.0 |
$2,804,000 |
|
12/19/2025
|
Sell |
Clark, Ian T. |
Director |
$29.7 |
$7,873,109 |
|
12/19/2025
|
Sell |
Myles, David C. |
CH. DISCOV. & NON-CLIN DEV OFF |
$30.0 |
$1,553,544 |
|
12/19/2025
|
Sell |
Zojwalla, Naseem |
Chief Medical Officer |
$28.5 |
$1,973,729 |
|
9/18/2025
|
Sell |
Harmon, Cyrus |
Director |
$8.3 |
$108,976 |
|
9/16/2025
|
Sell |
Harmon, Cyrus |
Director |
$8.1 |
$95,865 |
|
1/8/2025
|
Buy |
Bain Capital Life Sciences Investors, LLC |
Ten Percent Owner |
$5.8 |
$1,727,370 |
|
12/17/2024
|
Sell |
Graham, G. Walmsley |
Director |
$6.8 |
$9,460,274 |
|
12/13/2024
|
Sell |
Graham, G. Walmsley |
Director |
$6.8 |
$4,730,137 |
|
12/13/2024
|
Buy |
Graham, G. Walmsley |
Director |
$6.8 |
$4,730,137 |
|
12/11/2024
|
Sell |
Bohen, Sean |
PRESIDENT AND CEO |
$9.0 |
$496,052 |
|
12/11/2024
|
Sell |
Kovacs, Shane William Charles |
CH. OPERATING & FINANCIAL OFF. |
$9.0 |
$159,259 |
|
12/11/2024
|
Sell |
Zojwalla, Naseem |
CHIEF MEDICAL OFFICER |
$9.0 |
$125,994 |
|
12/11/2024
|
Sell |
Myles, David C. |
CH. DISCOV. & NON-CLIN DEV OFF |
$9.0 |
$118,116 |
|
12/11/2024
|
Sell |
Harmon, Cyrus |
Director |
$9.0 |
$70,597 |
|
12/10/2024
|
Sell |
Bohen, Sean |
PRESIDENT AND CEO |
$9.4 |
$490,313 |
|
12/10/2024
|
Sell |
Kovacs, Shane William Charles |
CH. OPERATING & FINANCIAL OFF. |
$9.4 |
$157,444 |
|
12/10/2024
|
Sell |
Zojwalla, Naseem |
CHIEF MEDICAL OFFICER |
$9.4 |
$124,462 |
|
12/10/2024
|
Sell |
Myles, David C. |
CH. DISCOV. & NON-CLIN DEV OFF |
$9.4 |
$116,800 |
|
12/10/2024
|
Sell |
Harmon, Cyrus |
Director |
$9.4 |
$77,359 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now